Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO International Convention Returns to San Diego…
20,000+ biotech leaders gather with a shared mission: to improve lives  SAN DIEGO (June 22, 2026) - The BIO International Convention (BIO 2026), the world’s largest and most comprehensive event for the biotechnology industry, begins today…
Learn more
BIO Statement on Veto of Prescription Drug…
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…
Learn more
BIO Statement on Resignation of FDA Commissioner…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
EU’s Anti-Science Comitology Reform Threatens Innovation
February 14, 2017
Washington, D.C. (February 14, 2017) – The European Commission announced today a proposal to revise its Comitology Regulation forcing policy decisions to individual EU member countries.
BIO Announces Gary Andres as the New Senior Executive Vice President of Public Affairs
February 14, 2017
Long-time Majority Staff Director of the House Energy and Commerce Committee Dr. Gary Andres joins BIO as Senior Executive Vice President of Public Affairs.
Registration Now Open for the 14th Annual BIO World Congress on Industrial Biotechnology
February 8, 2017
BIO announced registration and housing are now open for the 2017 World Congress on Industrial Biotechnology.  The conference will be held July 23-26, 2017 at the Palais des congrès de Montréal in Montréal,…
BIO Statement on President Trump’s Comments Supporting Biopharmaceutical Competition and Innovation
January 31, 2017
Washington, DC (January 31, 2017) – BIO issued the following statement regarding President Trump’s comments today supporting biopharmaceutical innovation:
BIO Statement on USDA and FDA Actions related to Pre-market Regulatory Oversight of Plant and Animal Organisms
January 18, 2017
The U.S. Department of Agriculture (USDA) and the U.S. Food and Drug Administration (FDA) published today four documents related to the pre-market regulatory oversight of a variety of biology-based agricultural tools, including genetically…
BIO’s Jim Greenwood Meets with India’s PM Modi
January 13, 2017
Delivers Message: India Must Protects Innovators’ Work Product
BIO Statement on Proposed Maryland Drug Pricing Legislation
January 10, 2017
BIO's statement  regarding proposed drug pricing legislation within the Maryland Senate.
BIO CEO & Investor Conference Programming Announced
December 15, 2016
BIO announced programming for the 19th annual BIO CEO & Investor Conference. Held February 13-14 at the Waldorf Astoria in New York, the annual conference provides an environment for investors, analysts, industry executives and others to…
BIO Applauds Senate Passage of the 21st Century Cures Act
December 7, 2016
Washington, DC (December 7, 2016) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement today regarding passage of the 21st Century Cures Act by the U.S. Senate:
BIO Applauds House Passage of the 21st Century Cures Act
November 30, 2016
Washington, DC (November 30, 2016) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement today regarding passage of the 21st Century Cures Act by the U.S. House of Representatives: